EGFR and breast cancer: In contrast, in breast cancer cells with the acquired resistance, increased crosstalk between ERα and other signal transduction pathways such as EGFR/HER256, IGF-IR53, and AKT/PTEN57 or altered expression of some key coregulators particularly reshuffle these highly dynamic gene looping resulting in altered chromatin reorganization.